Researchers discovered a new depression subtype, the 'cognitive biotype,' affecting 27% of patients who respond poorly to typically prescribed antidepressants. These patients struggle with planning, self-control, sustained focus, and suppressing inappropriate behavior, with brain scans revealing reduced activity in the regions responsible for these tasks.